Benzinga

Benzinga Japan

Benzinga

Benzinga Japan

Benzinga

Benzinga Japan
金曜日, 8 28

Guardant Health Inc

GHNASDAQ
Trade with Public
Trade with Public
$161.50
-7.02-4.17%
近くで: Aug 28, 5:00 PM EST
$161.50
N/A
時間外: 4:00 PM EST
概要ニュース業績予想イベント目標株価財務センチメント株主構成比較オプション株式レポート

Guardant Health Analyst Price Targets

Wall Street analyst price targets and consensus rating for Guardant Health (GH).

Price Target Range — 7 Quarters

Analyst Consensus — 24 Analysts

24Buy
Consensus RatingBuy# Analysts24Avg. Consensus PT$154Upside to Avg. PT-4.7%

Rating Trend — Last 9 Months

Recent Analyst Actions

View all ratings →
DateFirmAnalystActionRating ChangePrice Target
Aug 4, 2026Piper SandlerDavid WestenbergPT RaiseOverweight$135→$193
Aug 4, 2026Stephens & Co.Mason CarricoPT RaiseOverweight$170→$195
More with Benzinga EdgeGet Access

Analyst Ratings News

PRO
Piper Sandler Maintains Overweight on Guardant Health, Raises Price Target to $193

Piper Sandler analyst David Westenberg maintains Guardant Health (NASDAQ:GH) with a Overweight and raises the price target from $135 to $193.
Benzinga Newsdesk

PRO
Stephens & Co. Maintains Overweight on Guardant Health, Raises Price Target to $195

Stephens & Co. analyst Mason Carrico maintains Guardant Health (NASDAQ:GH) with a Overweight and raises the price target from $170 to $195.
Benzinga Newsdesk

PRO
Morgan Stanley Maintains Overweight on Guardant Health, Raises Price Target to $185

Morgan Stanley analyst Shannon O'Callaghan maintains Guardant Health (NASDAQ:GH) with a Overweight and raises the price target from $175 to $185.
Benzinga Newsdesk

PRO
Stifel Maintains Buy on Guardant Health, Raises Price Target to $180

Stifel analyst Daniel Arias maintains Guardant Health (NASDAQ:GH) with a Buy and raises the price target from $130 to $180.
Benzinga Newsdesk

PRO
RBC Capital Maintains Outperform on Guardant Health, Raises Price Target to $200

RBC Capital analyst Dan Leonard maintains Guardant Health (NASDAQ:GH) with a Outperform and raises the price target from $185 to $200.
Benzinga Newsdesk

PRO
Mizuho Maintains Outperform on Guardant Health, Raises Price Target to $200

Mizuho analyst Anthony Petrone maintains Guardant Health (NASDAQ:GH) with a Outperform and raises the price target from $175 to $200.
Benzinga Newsdesk

データとAPI: Benzinga API · 株式ニュースAPI · アナリスト評価API · 企業ロゴAPI

市場データ提供元 Benzinga API

Benzinga

Benzinga Japan

ニュース

パートナーシップ

ベンジンガ・グローバル

© 2026 Benzinga | All Rights Reserved